<DOC>
	<DOCNO>NCT00498238</DOCNO>
	<brief_summary>We evaluate effect levothyroxine subclinical hypothyroidism ( SCH ) arterial stiffness , lipid profile inflammation . Thirty-four patient SCH include . Patients treat levothyroxine 7 month . Arterial stiffness evaluate Augmentation index ( AIx ) . After accomplish euthyroidism , AIx decrease 8.3±17.2 6.5±14.3 ( P &lt; 0.01 ) AIx percentage decrease from36.2 11.5 ± 9.1±33.2 ( P =0.03 ) . Systolic blood pressure decrease 20±134.7 mmHg 13.7±127.6 ( P &lt; 0.01 ) . No significant improvement find parameter . In patient whose AIx 's decreased , LDL-cholesterol level decrease 37.1±-15.5 mg/dl compare patient whose AIx 's n't decrease LDL-cholesterol increase 57.4±24.1 mg/dl ( P=0.057 ) . We conclude patient suffer SCH , treatment levothyroxine significant beneficial effect arterial stiffness systolic blood pressure effect lipid profile inflammation .</brief_summary>
	<brief_title>The Effect Levothyroxine Arterial Stiffness Lipid Profile Patients With Subclinical Hypothyroidism</brief_title>
	<detailed_description>Subclinical hypothyroidism ( SCH ) disorder characterize high level thyrotropin ( thyroid stimulate hormone ( TSH ) ) , accompany normal level thyroxine ( T4 ) . There probably association SCH cardiovascular disease , however relationship SCH cardiovascular morbidity mortality still debate . Hak et al . Walsh et al . find patient SCH increase risk ischemic heart disease . Female smokers 50 year , TSH level 10 mU/L , high risk . However , study conduct Rodondi et al . find SCH increase risk cardiac ischemia , peripheral vascular disease cerebrovascular disease . Among risk factor atherosclerosis patient SCH hypertention , atherogenic lipid profile , high level c-reactive protein ( CRP ) , change clot system , endothelial dysfunction increase arterial stiffness . Studies show patient SCH suffer increase arterial stiffness endothelial dysfunction . One non invasive technique evaluate arterial stiffness pulse wave analysis ( PWA ) . PWA give information blood pressure aortic site rather peripherally . Recently , calculate AIx suggest independent risk marker cardiovascular adverse event . Obuobie et al . analyzed pressure wave velocity 12 patient overt hypothyroidism treat levothyroxine . They conclude hypothyroid patient treat levothyroxine decrease arterial stiffness treatment , although difference lipid profile find . Taddei et al . show patient SCH characterize endothelial dysfunction result reduction nitric oxide ( NO ) ; alteration partially independent dyslipidemia reverse levothyroxine treatment . The aim study assess effect levothyroxine treatment blood pressure , lipid profile , highly sensitive CRP ( hs- CRP ) arterial stiffness patient SCH . Whether SCH `` laboratory '' disease affect blood vessel question still controversy . We know yet levothyroxine therapy reverse `` silent '' problem SCH . Methods Patients Thirty four patient laboratory evidence subclinical hypothyroidism ( TSH level 4-25 mU/L normal T4 value ) least two follow test ( one month apart ) recruit endocrinology outpatient clinic study . The protocol approve local Helsinki Committee experiment Humans patient give inform consent . The exclusion criterion recent ( less 6 month ) myocardial infarction , cerebrovascular event angiography stent placement , serious infection month recruitment , use contrast medium last 6 month , loss 5 % body weight last 6 month , cardiac arrhythmia , ejection fraction le 40 % , active malignant disease , previous thyroid disease pregnancy . Study design The patient treat levothyroxine ( Eltroxin , Glaxo ) start dose 50 mcg per day . The follow conduct Research Development unit , Assaf Harofeh Medical Center 1 , 4 7 month post dose . In patient achieve normalization TSH , dose levothyroxine increase 100 mcg per day . At visit patient underwent physical examination include blood pressure , pulse weight . Blood pressure measure patient recumbent position . Blood drawn TSH , Hemoglobin , renal liver function , total cholesterol , high density lipoprotein-cholesterol ( HDL- cholesterol ) , triglyceride ( TG ) , oxidize low density lipoprotein ( ox-LDL ) hs- CRP . LDL-cholesterol calculate arterial stiffness assess . The patient ' medication regimen change throughout study period . Arterial stiffness Assessment arterial stiffness perform noninvasive technique use commercially available SphygmoCor System ( AtCor Medical LTD , Australia ) . All measurement perform patient recumbent position room temperature 25۫ C , 06:30 08:30 A.M. overnight fast ( 8-10 hour ) short period rest . Peripheral pressure waveform record radial artery wrist , use applanation tonometry high fidelity micromanometer . When sequential waveform record , validate 16-18 generalized transfer function apply generate corresponding central pressure waveform . The integral system software use calculate average radial artery waveform derive corresponding central aortic pressure waveform use previously validate generalize transfer function . From data index arterial stiffness obtain . The augmentation central arterial pressure difference first second systolic peak central pressure waveform , central augmentation index ( AIx ) augmentation express percentage pulse pressure . This technology easy perform , non-invasive , simple , rapid ( 15 minute per test ) repeatable . Oxidized LDL Blood sample collect EDTA contain tube . Separation plasma perform centrifugation 2500 RPM 10 minute . In order neutralize effect rheumatoid factor test accuracy , 5 % anti-interference reagent add plasma . Concentration ox-LDL determine use Elisa kit manufacture Dyne Diagnostic . Highly sensitive CRP Level measure use latex immunonephelometry technique accord manufacturer protocol . Levels determine concentration restriction 0.0175 mg/dL . Cholesterol HDL-cholesterol measure standard technique .</detailed_description>
	<mesh_term>Hypothyroidism</mesh_term>
	<criteria>Laboratory evidence subclinical hypothyroidism ( TSH level 425 mU/L normal T4 value ) least two follow test ( one month apart ) Recent ( less 6 month ) myocardial infarction , cerebrovascular event angiography stent placement Serious infection month recruitment Any use contrast medium last 6 month Loss 5 % body weight last 6 month Cardiac arrhythmia Ejection fraction le 40 % Active malignant diseases Previous thyroid disease Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Arterial stiffness , Augmentation index , Subclinical Hypothyroidism</keyword>
</DOC>